|
|
|
|
|
|
|
|
|
|
Article
"...While the compounds are currently being tested in Phase I and II trials, the authors are concerned that the long-term side effects of bone degradation and metastasis might not be noticed: Chang Yang, first author of the study, (Washington University School of Medicine) is wary that “these trials do not necessarily look for long-term effects of the drugs.” Continuing to explain this, Yang mentions that “if the cancer is going to metastasize to bone, it may take 6 months to 2 years to see that outcome. This may not be seen during the clinical trial.”....
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.